Updated Jul 16, 2026
Kosacz Barbara has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Barbara Kosacz is associated with Athira Pharma, Inc., a biotechnology company focused on developing therapies for neurodegenerative diseases. Specific details about her role and contributions to the company are not widely documented in publicly available sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | XOMA | XOMA Royalty Corp | J — Other acquisition / disposition | 6.3K | — | |
| 2026-05-26 | XOMA | XOMA Royalty Corp | A — Grant or award | 3.6K | $0.00 |
Barbara Kosacz is associated with Athira Pharma, Inc., a biotechnology company focused on developing therapies for neurodegenerative diseases. Specific details about her role and contributions to the company are not widely documented in publicly available sources.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kosacz Barbara profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.